Global trial to test pre-symptomatic Alzheimer's intervention in 1,600 adults

An international clinical study will screen 1,600 asymptomatic adults aged 55-80 for a biomarker linked to Alzheimer's risk, then test early intervention before cognitive decline. The approach is novel but efficacy remains unproven; results could shift prevention paradigms if successful.